PANACEA LIFE SCIENCES HOLDINGS, INC. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Panacea Life Sciences Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Panacea Life Sciences Holdings, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$1.06M, a 18% increase year-over-year.
  • Panacea Life Sciences Holdings, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$5.31M, a 0.37% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. annual Operating Income (Loss) for 2023 was -$5.55M, a 1.88% increase from 2022.
  • Panacea Life Sciences Holdings, Inc. annual Operating Income (Loss) for 2022 was -$5.65M, a 4.8% increase from 2021.
  • Panacea Life Sciences Holdings, Inc. annual Operating Income (Loss) for 2021 was -$5.94M, a 12.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$5.55M +$106K +1.88% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$5.65M +$285K +4.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$5.94M -$679K -12.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$5.26M +$5.41M +50.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$10.7M -$8.24M -338% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-23
2018 -$2.44M +$689K +22% Jan 1, 2018 Dec 31, 2018 10-K 2020-05-22
2017 -$3.12M -$1.52M -95.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 -$1.6M -$1.21M -311% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$389K +$31K +7.37% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 -$420K Jan 1, 2014 Dec 31, 2014 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.